v3.23.3
Condensed Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Operating activities:    
Net loss $ (7,005) $ (7,733)
Adjustments to reconcile net loss to net cash used in operating activities:    
Stock-based compensation expense 857 480
Amortization on leasehold improvement 6
Unrealized gain on change in fair value of common warrants classified as a liability (3,485)
Loss on financing common stock and common warrants 393
Changes in operating assets and liabilities:    
Prepaid expenses and other current assets 573 (47)
Deferred offering costs (41)
Accounts payable (184) 13
Accrued expenses 687 151
Net cash used in operating activities (8,205) (7,130)
Investing activities:    
Purchases of marketable securities (8,000)
Proceeds from maturities of marketable securities 2,992
Proceeds from sale of investments 2,032
Net cash provided by (used in) investing activities 2,032 (5,008)
Financing activities:    
Proceeds from common stock and pre-funded common warrants 5,000
Proceeds from exercise of stock options 8 39
Net cash provided by financing activities 5,008 39
Decrease in cash and cash equivalents (1,165) (12,099)
Cash and cash equivalents, beginning of period 4,391 15,192
Cash and cash equivalents, end of period 3,226 3,093
Supplemental of non-cash financing activities:    
Fair value of common warrant classified as a liability $ 1,908

Source

PDF HTML 10-Q Filing
ZIP XLS XBRL